Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene.
With recent advances in understanding of the neuroscience of risk taking, attention is now turning to genetic factors that may contribute to individual heterogeneity in risk attitudes. In this paper we test for genetic associations with risk attitude measures derived from both the psychology and economics literature. To develop a long-term prospective study, we first evaluate both types of risk attitudes and find that the economic and psychological measures are poorly correlated, suggesting that different genetic factors may underlie human response to risk faced in different behavioral domains. We then examine polymorphisms in a spectrum of candidate genes that affect neurotransmitter systems influencing dopamine regulation or are thought to be associated with risk attitudes or impulsive disorders. Analysis of the genotyping data identified two single nucleotide polymorphisms (SNPs) in the gene encoding the alpha 4 nicotine receptor (CHRNA4, rs4603829 and rs4522666) that are significantly associated with harm avoidance, a risk attitude measurement drawn from the psychology literature. Novelty seeking, another risk attitude measure from the psychology literature, is associated with several COMT (catechol-O-methyl transferase) SNPs while economic risk attitude measures are associated with several VMAT2 (vesicular monoamine transporter) SNPs, but the significance of these associations did not withstand statistical adjustment for multiple testing and requires larger cohorts. These exploratory results provide a starting point for understanding the genetic basis of risk attitudes by considering the range of methods available for measuring risk attitudes and by searching beyond the traditional direct focus on dopamine and serotonin receptor and transporter genes.
Roe
Brian E
BE
Department of Agricultural, Environmental and Development Economics, Ohio State University, Columbus, Ohio, USA. roe.30@osu.edu
Tilley
Michael R
MR
Gu
Howard H
HH
Beversdorf
David Q
DQ
Sadee
Wolfgang
W
Haab
Timothy C
TC
Papp
Audrey C
AC
D000328:Adult; D005260:Female; D005376:Financial Management; D006801:Humans; D008297:Male; D010551:Personality; D020641:Polymorphism, Single Nucleotide; D011978:Receptors, Nicotinic / Q000235:genetics*; D012309:Risk-Taking
D011978:Receptors, Nicotinic
Drug Alcohol Depend. 2006 Oct 1;84(3):231-9
16574343
Biol Psychiatry. 1997 Dec 1;42(11):1070-2
9386860
Int J Neuropsychopharmacol. 2007 Jun;10(3):309-20
17176492
Arch Gen Psychiatry. 1987 Jun;44(6):573-88
3579504
CNS Spectr. 2008 Apr;13(4):306-15
18408650
Neuropsychologia. 2008 Jan 31;46(2):757-63
18037454
J Neurosci Res. 2009 Feb;87(2):576-85
18803299
J Psychiatry Neurosci. 2007 Nov;32(6):412-6
18043764
J Gambl Stud. 2007 Jun;23(2):113-20
17205401
Addiction. 1998 Sep;93(9):1375-84
9926543
Neuroreport. 2004 Sep 15;15(13):2123-7
15486494
J Hum Genet. 2004;49(1):35-39
14685824
Hum Mol Genet. 2005 May 15;14(10):1393-404
15829504
Curr Opin Neurol. 2007 Aug;20(4):484-92
17620886
Neuropsychologia. 2001;39(4):376-89
11164876
Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):617-22
19104049
PLoS One. 2009;4(2):e4362
19209222
Psychiatr Dev. 1986 Autumn;4(3):167-226
3809156
J Addict Dis. 2001;20(4):91-6
11760929
Am J Psychiatry. 2003 Jan;160(1):47-55
12505801
Genes Brain Behav. 2008 Mar;7(2):164-72
17559419
Arch Neurol. 2007 Feb;64(2):212-6
17296836
J Neural Transm (Vienna). 2003 Dec;110(12):1445-53
14666415
Neuroreport. 2009 Jan 7;20(1):19-23
19034055
Hum Mol Genet. 2006 Jan 15;15(2):299-305
16339215
Nat Genet. 1996 Jan;12(1):78-80
8528256
Neuropsychopharmacology. 2005 Dec;30(12):2263-8
15988470
Am J Med Genet. 2000 Jun 12;96(3):360-4
10898915
Arch Gen Psychiatry. 2007 Sep;64(9):1078-86
17768273
Compr Psychiatry. 2006 Sep-Oct;47(5):350-6
16905396
Hum Genet. 2006 Nov;120(4):447-59
16896926
Psychiatr Genet. 2008 Aug;18(4):167-76
18628678
Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1442-9
18165969
Mol Psychiatry. 2001 Jan;6(1):35-8
11244482
Clin Genet. 2000 Nov;58(5):375-85
11140838
J Affect Disord. 1996 Apr 12;37(2-3):75-9
8731069
Brain Cogn. 2008 Apr;66(3):243-52
17942206
Neuropsychobiology. 2004;50(2):153-6
15292670
Acta Psychiatr Scand. 2000 May;101(5):403-5
10823301
Nat Rev Neurosci. 2004 Jan;5(1):55-65
14708004
Compr Psychiatry. 2007 Sep-Oct;48(5):452-7
17707254
Mol Psychiatry. 2003 Jan;8(1):118-22
12556917
Neuropsychologia. 2007 Sep 20;45(12):2874-81
17603086
Twin Res Hum Genet. 2009 Feb;12(1):103-7
19210185
J Psychiatr Res. 1996 Jan-Feb;30(1):21-7
8736463
Neuroreport. 2005 Jul 13;16(10):1135-8
15973162
Alcohol Clin Exp Res. 2008 Jan;32(1):27-35
18070248
Neuropsychopharmacology. 2007 Sep;32(9):1950-5
17299513
Cereb Cortex. 2008 Jan;18(1):46-52
17412719
Neuroimage. 2003 Aug;19(4):1439-48
12948701
Neuropsychopharmacology. 2005 Jul;30(7):1353-61
15770238